Ermac, Baby Boy .
HRN: 26-37-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/19/2024
12/26/2024
IV
27mg
OD
PSNB
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes